SANTA CLARA, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced the company will be participating in the upcoming Bank of America Merrill Lynch 2019 Health Care Conference being held from May 14-16, 2019 in Las Vegas, NV.

Shockwave Medical’s management is scheduled to present on Wednesday, May 15, 2019 at 2:35 p.m. Pacific Time.  Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://ir.shockwavemedical.com/.

About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated by establishing a new standard of care with Intravascular Lithotripsy (IVL) technology. The company’s differentiated and proprietary IVL approach to calcium modification uses sonic pressure waves to safely and effectively fracture problematic calcium throughout the cardiovascular system in a wide and growing number of applications. For more information, visit www.shockwavemedical.com. 

Investor Contact:
Debbie Kaster, Gilmartin Group
investors@shockwavemedical.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.